Closely monitor vital signs, including blood pressure, heart rate, and respiratory rate, at least every 15 minutes during the initial infusion and then according to the patient’s response and clinical status. Observe for signs of hypovolemia such as hypotension, tachycardia, and decreased urine output.
Regularly assess fluid balance by measuring intake and output. Pay close attention to urine output; a significant decrease may indicate dehydration or kidney dysfunction. Weigh the patient daily to track fluid status.
Monitor serum electrolytes, particularly potassium, sodium, calcium, and magnesium, as Lasix can induce electrolyte imbalances. These imbalances can cause serious cardiac arrhythmias. Frequent blood tests may be required depending on the patient’s condition and response to treatment.
Continuously assess the patient’s mental status, looking for signs of confusion or disorientation, which can be associated with electrolyte abnormalities.
Check for signs of ototoxicity such as tinnitus or hearing loss, especially with high doses or prolonged use. Report any such symptoms immediately.
Document all findings meticulously, including vital signs, fluid balance, electrolyte levels, and any adverse effects. This detailed documentation supports prompt identification of complications and allows for effective treatment adjustments.
